Although the role of CD133 has not been fully understood, it has been hypothesized that its expression may confer self-renewal capacity, dedifferentiation/stem cell-like properties and anti-apoptotic behavior to a specific population of esophageal cancer stem cells, thus promoting chemoresistance and tumor recurrence 54. The gene discussed is PROM1; the disease is neoplasm.